The Business Brew10 Jun 2021

Jason Buck - Survive Like A Cockroach

Jason Buck (@JasonMutiny on Twitter), Co Founder and CIO of Mutiny Funds, stopped by for the first in person interview on The Business Brew. Mutiny is releasing the Cockroach Portfolio, a portfolio designed to survive any market conditions. See https://mutinyfund.com/ for details. In this episode Jason discusses his history as an entrepreneur, which took a hit in the Great Financial Crisis. That event caused Jason to think about whether it was possible to hedge entrepreneurial risk. After years of thought, the Cockroach Portfolio was born. The goal of the Cockroach Portfolio is to keep wealth in all market conditions. This conversation goes all over the place. We hope you enjoy. ~4:05 - Trading VIX ~9:00 - Jason's history as a real estate entrepreneur ~10:00 - How often "black swans" occur ~16:50 - Jason describes thinking about hedging macro/entrepreneurial risk ~18:00 - Shannon's Demon - see also https://quant.stackexchange.com/questions/38473/intuitive-explanation-for-shannons-demon ~22:30 - How would Buffett behave if he were starting today? ~23:35 - The $SHIT ETF ~29:17 - What it's like to lose everything ~32:00 - Keeping wealth vs. making wealth ~37:50 - The Hypomanic's Edge ~41:00 - How Jason and Taylor "solved" the problem they wanted to solve ~48:07 - Be so good they can't ignore you ~49:20 - Selecting the right partners ~55:00 - Building the Cockroach Portfolio the right way ~1:04:00 - Playing better games than stock picking; compounding capital without tax ~1:09:00 - What lies do we tell ourselves? ~1:13:00 - Laying asymmetric bets ~1:17:00 - Mental health and whether substances risk mental health ~1:18:00 - General mental health discussion and habits to keep healthy ~1:29:00 - General podcast and Pirates Of Finance Discussion; see https://www.youtube.com/channel/UCsfk98XxbnjTCLkROQZ5zWg/featured ~1:37:00 - Back to Mutiny Fund and how it's structured ~1:40:00 - Avoiding big drawdowns

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(202)

Steve Hou - Data Over Narrative

Steve Hou, Head of Research at Silicon Data, stops by to discuss solving problems associated with AI capex financing. Silicon Data provides users with a number of indices and data sets tracking everyt...

23 Sep 1h 16min

Another Cyclical Masterclass with Robotti & Company

Bob Robotti stops by for a follow up episode. David Kessler, Portfolio Manager and Securities Analyst at Robotti & Company, is in the room with Bob to provide some additional analytical firepower. Thi...

27 Aug 1h 38min

Another FDA vs uniQure Episode

Peter Mantas returns to the show. This is a follow up episode to the episode discussing uniQure. It's timely given the amount of media attention Marty Makary is getting; in part because of uniQure. De...

7 Mai 1h 20min

Revisiting Fairfax Financial

Charles Frischer and Asheef Lalani stop by The Business Brew to update the listeners on Fairfax Financial. They originally came on the program on 7/20/2023 when the stock was quite unloved. Bill asked...

30 Apr 1h 31min

Evan Tindell

Evan Tindell, CIO at Bireme Capital, returns to The Brew for a laid back conversation. The impetus for the conversation is Evan's Q4 letter. A year ago Evan came on the show to educate people about ...

24 Apr 1h 37min

Sonu Chawla - Managing Mid Cap Exposure - $TSCM

Sonu Chawla of Times Square Capital Management shares her investment philosophy, focusing on growth with a conscience, valuation discipline, and management assessment. Stocks discussed include Argenx,...

26 Mar 1h 12min

Notes From The Beauty Contest

@crashkolnikov on X, and author of Notes From The Beauty Contest Substack, joins the show. Notes From The Beauty Contest is a long form Substack that focuses on stocks that are somewhat under covered ...

21 Mar 1h 51min

Current Events - uniQure and the FDA

uniQure is a business that develops gene therapies. uniQure's AMT-130 is currently in the headlines. This podcast episode attempts to present the Huntington's Disease community's arguments for why the...

6 Mar 1h 35min